{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:42:10Z","timestamp":1786718530482,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Reprod Sci"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/jhrs.jhrs_102_17","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T03:44:46Z","timestamp":1524800686000},"page":"271","source":"Crossref","is-referenced-by-count":12,"title":["Repeat dose of gonadotropin-releasing hormone agonist trigger in polycystic ovarian syndrome undergoing In Vitro fertilization cycles provides a better cycle outcome - a proof-of-concept study"],"prefix":"10.4103","volume":"10","author":[{"given":"Krishna","family":"Deepika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pookilath","family":"Baiju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praneesh","family":"Gautham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathore","family":"Suvarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vohra","family":"Arveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rao","family":"Kamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-1208.223273-1","first-page":"709","volume-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.223273-2","first-page":"506","volume-title":"Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome","author":"Emperaire","year":"1991","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.223273-3","first-page":"97","volume-title":"Use of GnRH analog for induction of the ovulatory surge of gonadotropins in patients at risk of the ovarian hyperstimulation syndrome","author":"Kulikowski","year":"1995","journal-title":"Gynecol Endocrinol"},{"key":"key-10.4103\/0974-1208.223273-4","first-page":"1965","volume-title":"Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: Preliminary report: Short communication","author":"Itskovitz-Eldor","year":"2000","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.223273-5","first-page":"639","volume-title":"GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS","author":"Engmann","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/0974-1208.223273-6","first-page":"84","volume-title":"The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: A prospective randomized controlled study","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-7","first-page":"389","volume-title":"Preventing ovarian hyperstimulation syndrome: Guidance for the clinician","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-8","first-page":"510","volume-title":"GnRH agonist for triggering of final oocyte maturation: Time for a change of practice?","author":"Humaidan","year":"2011","journal-title":"Hum Reprod Update"},{"key":"key-10.4103\/0974-1208.223273-9","first-page":"2029","volume-title":"Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a \u201cfreeze-all\u201d strategy: A prospective multicentric study","author":"Griesinger","year":"2011","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-10","first-page":"239","volume-title":"Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: Two case reports","author":"Honnma","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key-10.4103\/0974-1208.223273-11","first-page":"249","volume-title":"Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS","author":"Castillo","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"key-10.4103\/0974-1208.223273-12","first-page":"264","volume-title":"Use of gonadotropin-releasing hormone agonist trigger during in vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome","author":"O'Neill","year":"2015","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-13","first-page":"19","volume-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","author":"Rotterdam","year":"2004","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-14","first-page":"365","volume-title":"Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: Findings of a large retrospective cohort study","author":"Bodri","year":"2009","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-15","first-page":"632","volume-title":"Istanbul consensus workshop on embryo assessment: Proceedings of an expert meeting","author":"ALPHA","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/0974-1208.223273-16","first-page":"608","volume-title":"Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination","author":"Kuwayama","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/0974-1208.223273-17","first-page":"141","volume-title":"The lutropin\/choriogonadotropin receptor, a 2002 perspective","author":"Ascoli","year":"2002","journal-title":"Endocr Rev"},{"key":"key-10.4103\/0974-1208.223273-18","first-page":"1763","volume-title":"Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man","author":"Yen","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.223273-19","first-page":"1","volume-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","author":"Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-20","first-page":"1111","volume-title":"Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting","author":"DiLuigi","year":"2010","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-21","first-page":"792","volume-title":"Hormonal dynamics at midcycle: A reevaluation","author":"Hoff","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.223273-22","first-page":"213","volume-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-23","doi-asserted-by":"crossref","unstructured":"Zelinski-Wooten MB, Lanzendorf SE, Wolf DP, Chandrasekher YA, Stouffer RL. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function. J Clin Endocrinol Metab 1991;73:577-83.","DOI":"10.1210\/jcem-73-3-577"},{"key":"key-10.4103\/0974-1208.223273-24","first-page":"568","volume-title":"The temporal relationship between the luteinizing hormone surge and human oocyte maturation","author":"Seibel","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/0974-1208.223273-25","first-page":"502","volume-title":"Administration of human luteinizing hormone (hLH) to macaques after follicular development: Further titration of LH surge requirements for ovulatory changes in primate follicles","author":"Zelinski-Wooten","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0974-1208.223273-26","first-page":"637","volume-title":"Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles","author":"Meyer","year":"2015","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-27","first-page":"2593","volume-title":"An OHSS-free clinic by segmentation of IVF treatment","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.223273-28","first-page":"CD008046","volume-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0974-1208.223273-29","first-page":"1976","volume-title":"Arandomized controlled study of human day 3 embryo cryopreservation by slow freezing or vitrification: Vitrification is associated with higher survival, metabolism and blastocyst formation","author":"Balaban","year":"2008","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.223273-30","first-page":"368","volume-title":"Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: A systematic review and meta-analysis","author":"Maheshwari","year":"2012","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-31","first-page":"5694","volume-title":"Studies on the role of plasminogen activator in ovulation.In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins","author":"Strickland","year":"1976","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-1208.223273-32","first-page":"483","volume-title":"FSH stimulates hyaluronic acid synthesis by oocyte-cumulus cell complexes from mouse preovulatory follicles","author":"Eppig","year":"1979","journal-title":"Nature"},{"key":"key-10.4103\/0974-1208.223273-33","first-page":"726","volume-title":"FSH-induced resumption of meiosis in mouse oocytes: Effect of different isoforms","author":"Yding","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"key-10.4103\/0974-1208.223273-34","first-page":"328","volume-title":"Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization","author":"Imoedemhe","year":"1991","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-35","first-page":"1213","volume-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: A prospective randomized study","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.223273-36","first-page":"783","volume-title":"GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor\/FSH stimulation","author":"Oktay","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"key-10.4103\/0974-1208.223273-37","first-page":"317","volume-title":"Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development","author":"Chung","year":"2011","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-38","first-page":"152","volume-title":"Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger","author":"Kummer","year":"2013","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.223273-39","first-page":"826","volume-title":"Efficacy of induced luteinizing hormone surge after \u201ctrigger\u201d with gonadotropin-releasing hormone agonist","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"key-10.4103\/0974-1208.223273-40","first-page":"2703","volume-title":"Empty follicle syndrome due to human errors: Its occurrence in an in-vitro fertilization programme","author":"Quintans","year":"1998","journal-title":"Hum Reprod"},{"key":"key-10.4103\/0974-1208.223273-41","first-page":"1375","volume-title":"The prevalence of genuine empty follicle syndrome","author":"Mesen","year":"2011","journal-title":"Fertil Steril"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:36:08Z","timestamp":1786714568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.JHRS_102_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["223273"],"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_102_17","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}